Although MS and psychostimulants have been shown to individually affect epigenetic factors such as MeCP2, and MeCP2 has been implicated in drug seeking behavior, it is yet to be determined if MS and, specifically, METH also interact to affect epigenetic factors. Here, MECP2 is linked to myeloid sarcoma.